IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i24p16518-d998068.html
   My bibliography  Save this article

A Scoping Review of the Use of Pioglitazone in the Treatment of Temporo-Mandibular Joint Arthritis

Author

Listed:
  • Natalia Turosz

    (Ortomania, Bartosza Głowackiego 6/1, 30-085 Kraków, Poland)

  • Kamila Chęcińska

    (Department of Glass Technology and Amorphous Coatings, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Kraków, Poland)

  • Maciej Chęciński

    (Department of Oral Surgery, Preventive Medicine Center, Komorowskiego 12, 30-106 Kraków, Poland)

  • Monika Kamińska

    (Collegium Medicum, Jan Kochanowski University, aleja IX Wieków Kielc 19A, 25-317 Kielce, Poland)

  • Zuzanna Nowak

    (Department of Temporomandibular Disorders, Medical University of Silesia in Katowice, Traugutta sq.2, 41-800 Zabrze, Poland)

  • Maciej Sikora

    (Department of Maxillofacial Surgery, Hospital of the Ministry of Interior, Wojska Polskiego 51, 25-375 Kielce, Poland
    Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland)

  • Dariusz Chlubek

    (Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland)

Abstract

Thiazolidinediones (TZDs) are a group of diabetes medications currently being investigated for anti-arthritis effectiveness, one of which is pioglitazone. The purpose of this scoping review is to evaluate the potential use of pioglitazone in the treatment of temporomandibular joint (TMJ) arthritis. The criteria of eligibility were studies with the diagnosis of arthritis and pioglitazone treatment with a change in any inflammation index as an outcome. Of the 1169 records initially identified following the selection process, two animal studies and four clinical studies were included in the review. Improvements from the baseline were observed in each treatment group for each inflammation indicator. The results of the animal studies on the temporomandibular joints and on patients with rheumatoid and psoriatic arthritis indicate that the drug in question may have potential to treat arthritis, including within the temporomandibular joint.

Suggested Citation

  • Natalia Turosz & Kamila Chęcińska & Maciej Chęciński & Monika Kamińska & Zuzanna Nowak & Maciej Sikora & Dariusz Chlubek, 2022. "A Scoping Review of the Use of Pioglitazone in the Treatment of Temporo-Mandibular Joint Arthritis," IJERPH, MDPI, vol. 19(24), pages 1-17, December.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:24:p:16518-:d:998068
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/24/16518/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/24/16518/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Zuzanna Nowak & Maciej Chęciński & Aleksandra Nitecka-Buchta & Sylwia Bulanda & Danuta Ilczuk-Rypuła & Lidia Postek-Stefańska & Stefan Baron, 2021. "Intramuscular Injections and Dry Needling within Masticatory Muscles in Management of Myofascial Pain. Systematic Review of Clinical Trials," IJERPH, MDPI, vol. 18(18), pages 1-19, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Maciej Sikora & Marcin Sielski & Maciej Chęciński & Kamila Chęcińska & Barbara Czerwińska-Niezabitowska & Dariusz Chlubek, 2022. "Patient-Reported Quality of Life versus Physical Examination in Treating Temporomandibular Disorders with Intra-Articular Platelet-Rich Plasma Injections: An Open-Label Clinical Trial," IJERPH, MDPI, vol. 19(20), pages 1-13, October.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:24:p:16518-:d:998068. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.